Federal SB1500 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal SB1500, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. These examinations include diagnostic mammography, breast magnetic resonance imaging, and breast ultrasound. The bill also ensures that plans are not disqualified as high deductible health plans for not having a deductible for these examinations. The changes apply to plan years beginning on or after January 1, 2026.

Federal SB1500 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal SB1500, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. These examinations include diagnostic mammography, breast magnetic resonance imaging, and breast ultrasound. The bill also ensures that plans are not disqualified as high deductible health plans for not having a deductible for these examinations. The changes apply to plan years beginning on or after January 1, 2026.